官方服务：
资源简介：
Haploid genetic screen for drug resistance
应用场景：
创建时间：
2018-11-23
相关数据集
CD47 2D genomic screen
FACS-based haploid genetic screen on a-hCD47-BH612 (“B6H12”) and a-hCD47-CC2C6 (“CC2C6”) double-stained cells, employing a 4-way sorting strategy to distinguish regulators that affect CD47 levels or t
NIAID Data Ecosystem60
Comparative haploid genetic screens reveal divergent pathways in the biogenesis and trafficking of glycophosphatidylinositol (GPI)-anchored proteins. Homo sapiens
Comparative haploid genetic screens to annotate common and specialized genes required for the biogenesis of individual GPI anchored proteins. SEC62 and SEC63 were required for proper PrP targeting, an
NIAID Data Ecosystem40
Haploid screen for macroH2A regulators
Haploid genetic screen to identify genes affecting macroH2A incorporation in chromatin.
NIAID Data Ecosystem20
Haploid screen for macroH2A regulators
Haploid genetic screen to identify genes affecting macroH2A incorporation in chromatin.
NIAID Data Ecosystem40
A genome-wide screen in the yeast diploid deletion collection identifies 209 doxorubicin resistance genes enriched for those that show cross sensitivity to zymocin, ionizing radiation, loss of G1 size control and oxidative damage.
1Resistance to the G1 specific toxin zymocin was determined in a screen that was performed in parallel to that for the identification of DOX resistance mutants. A total of 806 diploid deletion strains
NIAID Data Ecosystem20
